Genome Engineering for Humanity
PIPELINE
OVERVIEW
- Monoclonal antibody
HM-001
-
Solid tumors
- Oncology
- Discovery stage
- Immune checklioint inhibitor
- Monoclonal antibody
HM-002
-
Solid tumors
- Oncology
- Discovery stage
- Stromal modulator
- Monoclonal antibody
HM-101
-
Autoimmune disease
- Inflammation & Immunology
- Discovery stage
- T-cell immune modulator
- Monoclonal antibody
HM-201
-
Neuroimmune disorder
- Neuroscience
- Discovery stage
- T-cell immune modulator
Pipeline Development Portfolio
| Pipeline | Therapeutic area | Modality | MOA | Development status | Indication(s) | |||
|---|---|---|---|---|---|---|---|---|
| Discovery | Preclinical | Phase 1 | Phase 2 | |||||
| HM-001 | Oncology | mAb | Immune checkpoint inhibitor | Solid tumors | ||||
| HM-002 | Oncology | mAb | Stromal modulator | Solid tumors | ||||
| HM-101 | Inflammaton & Immunology | mAb | Immune modulator | Atopic dermatitis | ||||
| HM-201 | Neuroscience | mAb | Immune modulator | Autism spectrum disorder (ASD) | ||||